{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:03:06Z","timestamp":1792803786595,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09587-x","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:00:50Z","timestamp":1769101250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epithelial-mesenchymal plasticity and immunosuppression in canine carcinomas reveals cross-species upregulation of CD109"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7122-0989","authenticated-orcid":false,"given":"Kimaya","family":"Bakhle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Nelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynna","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Ntekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwijn","family":"De Vlaminck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4167-6272","authenticated-orcid":false,"given":"Santiago","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5688-1132","authenticated-orcid":false,"given":"Anushka","family":"Dongre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"9587_CR1","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.cell.2011.04.029","volume":"145","author":"C Scheel","year":"2011","unstructured":"Scheel, C. et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145, 926\u2013940 (2011).","journal-title":"Cell"},{"key":"9587_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.celrep.2014.12.032","volume":"10","author":"JM Schmidt","year":"2015","unstructured":"Schmidt, J. M. et al. Stem-cell-like properties and epithelial plasticity arise as stable traits after transient Twist1 activation. Cell Rep. 10, 131\u2013139 (2015).","journal-title":"Cell Rep."},{"key":"9587_CR3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2012.02.008","volume":"148","author":"W Guo","year":"2012","unstructured":"Guo, W. et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148, 1015\u20131028 (2012).","journal-title":"Cell"},{"key":"9587_CR4","doi-asserted-by":"publisher","first-page":"e2888","DOI":"10.1371\/journal.pone.0002888","volume":"3","author":"A-P Morel","year":"2008","unstructured":"Morel, A.-P. et al. Generation of breast cancer stem cells through epithelial\u2013mesenchymal transition. PLoS ONE 3, e2888 (2008).","journal-title":"PLoS ONE"},{"key":"9587_CR5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704\u2013715 (2008).","journal-title":"Cell"},{"key":"9587_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature14897","volume":"525","author":"X Ye","year":"2015","unstructured":"Ye, X. et al. Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature 525, 256\u2013260 (2015).","journal-title":"Nature"},{"key":"9587_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","volume":"21","author":"AW Lambert","year":"2021","unstructured":"Lambert, A. W. & Weinberg, R. A. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat. Rev. Cancer 21, 325\u2013338 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"9587_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20, 69\u201384 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"9587_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10555-016-9648-7","volume":"35","author":"CL Chaffer","year":"2016","unstructured":"Chaffer, C. L., San Juan, B. P., Lim, E. & Weinberg, R. A. EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 35, 645\u2013654 (2016).","journal-title":"Cancer Metastasis Rev."},{"key":"9587_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/sj.bjc.6602266","volume":"92","author":"A Miyoshi","year":"2005","unstructured":"Miyoshi, A. et al. Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br. J. Cancer 92, 252\u2013258 (2005).","journal-title":"Br. J. Cancer"},{"key":"9587_CR11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","volume":"19","author":"AM Krebs","year":"2017","unstructured":"Krebs, A. M. et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat. Cell Biol. 19, 518\u2013529 (2017).","journal-title":"Nat. Cell Biol."},{"key":"9587_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrc2389","volume":"8","author":"A Klaus","year":"2008","unstructured":"Klaus, A. & Birchmeier, W. Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer 8, 387\u2013398 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"9587_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-014-0087-z","volume":"7","author":"X Yuan","year":"2014","unstructured":"Yuan, X. et al. Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application. J. Hematol. Oncol. 7, 87 (2014).","journal-title":"J. Hematol. Oncol."},{"key":"9587_CR14","doi-asserted-by":"publisher","first-page":"36869","DOI":"10.18632\/oncotarget.16300","volume":"8","author":"M Di Domenico","year":"2017","unstructured":"Di Domenico, M. & Giordano, A. Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion. Oncotarget 8, 36869\u201336884 (2017).","journal-title":"Oncotarget"},{"key":"9587_CR15","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1038\/sj.emboj.7601213","volume":"25","author":"S Grotegut","year":"2006","unstructured":"Grotegut, S., von Schweinitz, D., Christofori, G. & Lehembre, F. Hepatocyte growth factor induces cell scattering through MAPK\/Egr-1-mediated upregulation of Snail. EMBO J. 25, 3534\u20133545 (2006).","journal-title":"EMBO J."},{"key":"9587_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu, J., Lamouille, S. & Derynck, R. TGF-\u03b2-induced epithelial to mesenchymal transition. Cell Res. 19, 156\u2013172 (2009).","journal-title":"Cell Res."},{"key":"9587_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat. Rev. Mol. Cell Biol. 21, 341\u2013352 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"9587_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko, I. & Blanpain, C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 29, 212\u2013226 (2019).","journal-title":"Trends Cell Biol."},{"key":"9587_CR19","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1073\/pnas.1812876116","volume":"116","author":"C Kr\u00f6ger","year":"2019","unstructured":"Kr\u00f6ger, C. et al. Acquisition of a hybrid E\/M state is essential for tumorigenicity of basal breast cancer cells. Proc. Natl. Acad. Sci. USA 116, 7353\u20137362 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9587_CR20","doi-asserted-by":"publisher","first-page":"E2337","DOI":"10.1073\/pnas.1618298114","volume":"114","author":"B Bierie","year":"2017","unstructured":"Bierie, B. et al. Integrin-\u03b24 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proc. Natl. Acad. Sci. USA 114, E2337\u2013E2346 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9587_CR21","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1158\/0008-5472.CAN-16-3292","volume":"77","author":"A Dongre","year":"2017","unstructured":"Dongre, A. et al. Epithelial-to-mesenchymal transition contributes to Immunosuppression in breast carcinomas. Cancer Res. 77, 3982\u20133989 (2017).","journal-title":"Cancer Res."},{"key":"9587_CR22","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1158\/2159-8290.CD-20-0603","volume":"11","author":"A Dongre","year":"2021","unstructured":"Dongre, A. et al. Direct and indirect regulators of epithelial\u2013mesenchymal transition-mediated immunosuppression in breast carcinomas. Cancer Discov. 11, 1286\u20131305 (2021).","journal-title":"Cancer Discov."},{"key":"9587_CR23","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/0008-5472.CAN-15-0977","volume":"76","author":"L-Y Ye","year":"2016","unstructured":"Ye, L.-Y. et al. Hypoxia-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma induces an immunosuppressive tumor microenvironment to promote metastasis. Cancer Res. 76, 818\u2013830 (2016).","journal-title":"Cancer Res."},{"key":"9587_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6241","volume":"5","author":"L Chen","year":"2014","unstructured":"Chen, L. et al. Metastasis is regulated via microRNA-200\/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat. Commun. 5, 5241 (2014).","journal-title":"Nat. Commun."},{"key":"9587_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ccr.2009.01.023","volume":"15","author":"C Kudo-Saito","year":"2009","unstructured":"Kudo-Saito, C., Shirako, H., Takeuchi, T. & Kawakami, Y. Cancer metastasis is accelerated through immunosuppression during snail-induced EMT of cancer cells. Cancer Cell 15, 195\u2013206 (2009).","journal-title":"Cancer Cell"},{"key":"9587_CR26","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1158\/1078-0432.CCR-06-0478","volume":"12","author":"C C\u00f4me","year":"2006","unstructured":"C\u00f4me, C. et al. Snail and slug play distinct roles during breast carcinoma progression. Clin. Cancer Res. 12, 5395\u20135402 (2006).","journal-title":"Clin. Cancer Res."},{"key":"9587_CR27","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.ccell.2021.05.005","volume":"39","author":"KP Simeonov","year":"2021","unstructured":"Simeonov, K. P. et al. Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states. Cancer Cell 39, 1150\u20131162.e9 (2021).","journal-title":"Cancer Cell"},{"key":"9587_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13423","volume":"56","author":"D Li","year":"2023","unstructured":"Li, D. et al. Heterogeneity and plasticity of epithelial\u2013mesenchymal transition (EMT) in cancer metastasis: focusing on partial EMT and regulatory mechanisms. Cell Prolif. 56, e13423 (2023).","journal-title":"Cell Prolif."},{"key":"9587_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj8002","volume":"8","author":"MS Brown","year":"2022","unstructured":"Brown, M. S. et al. Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer. Sci. Adv. 8, eabj8002 (2022).","journal-title":"Sci. Adv."},{"key":"9587_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36439-7","volume":"14","author":"G Malagoli Tagliazucchi","year":"2023","unstructured":"Malagoli Tagliazucchi, G., Wiecek, A. J., Withnell, E. & Secrier, M. Genomic and microenvironmental heterogeneity shaping epithelial-to-mesenchymal trajectories in cancer. Nat. Commun. 14, 789 (2023).","journal-title":"Nat. Commun."},{"key":"9587_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc.2017.86","volume":"17","author":"D Vijayan","year":"2017","unstructured":"Vijayan, D., Young, A., Teng, M. W. L. & Smyth, M. J. Targeting immunosuppressive adenosine in cancer. Nat. Rev. Cancer 17, 709\u2013724 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"9587_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","volume":"17","author":"B Allard","year":"2020","unstructured":"Allard, B., Allard, D., Buisseret, L. & Stagg, J. The adenosine pathway in immuno-oncology. Nat. Rev. Clin. Oncol. 17, 611\u2013629 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"9587_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","volume":"19","author":"L Kraehenbuehl","year":"2022","unstructured":"Kraehenbuehl, L., Weng, C.-H., Eghbali, S., Wolchok, J. D. & Merghoub, T. Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways. Nat. Rev. Clin. Oncol. 19, 37\u201350 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"9587_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2012.04623.x","volume":"171","author":"FS Regateiro","year":"2013","unstructured":"Regateiro, F. S., Cobbold, S. P. & Waldmann, H. CD73 and adenosine generation in the creation of regulatory microenvironments. Clin. Exp. Immunol. 171, 1\u20137 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"9587_CR35","doi-asserted-by":"publisher","first-page":"447851","DOI":"10.3389\/fimmu.2019.00925","volume":"10","author":"S Vigano","year":"2019","unstructured":"Vigano, S. et al. Targeting adenosine in cancer immunotherapy to enhance T-cell function. Front. Immunol. 10, 447851 (2019).","journal-title":"Front. Immunol."},{"key":"9587_CR36","doi-asserted-by":"crossref","unstructured":"London, C. A. et al. Leading the pack: best practices in comparative canine cancer genomics to inform human oncology. Vet. Comp. Oncol.\u00a021, 565\u2013577 (2023).","DOI":"10.1111\/vco.12935"},{"key":"9587_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0200-7","volume":"4","author":"JS Park","year":"2016","unstructured":"Park, J. S. et al. Canine cancer immunotherapy studies: linking mouse and human. J. Immunother. Cancer 4, 97 (2016).","journal-title":"J. Immunother. Cancer"},{"key":"9587_CR38","doi-asserted-by":"crossref","unstructured":"Nance, R. L., Sajib, A. M. & Smith, B. F. Canine models of human cancer: Bridging the gap to improve precision medicine. In Progress in Molecular Biology and Translational Science Vol. 189 (ed. Tao, Y.-X.) 67\u201399 (Academic Press, 2022).","DOI":"10.1016\/bs.pmbts.2021.12.003"},{"key":"9587_CR39","doi-asserted-by":"crossref","unstructured":"Dow, S. A role for dogs in advancing cancer immunotherapy research. Front. Immunol. 10, (2020).","DOI":"10.3389\/fimmu.2019.02935"},{"key":"9587_CR40","first-page":"607","volume":"10","author":"EMG da Silva","year":"2023","unstructured":"da Silva, E. M. G., dos, Santos, T. R. & Silva, M. J. B. Identifying the risk factors for malignant mammary tumors in dogs: a Retrospective study. Vet. Sci. 10, 607 (2023).","journal-title":"Vet. Sci."},{"key":"9587_CR41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/rda.14408","volume":"58","author":"J-S Fr\u00e9nel","year":"2023","unstructured":"Fr\u00e9nel, J.-S. & Nguyen, F. Mammary carcinoma: comparative oncology between small animals and humans\u2014new therapeutic tools. Reprod. Domest. Anim. 58, 102\u2013108 (2023).","journal-title":"Reprod. Domest. Anim."},{"key":"9587_CR42","doi-asserted-by":"publisher","first-page":"e0127381","DOI":"10.1371\/journal.pone.0127381","volume":"10","author":"Y Salas","year":"2015","unstructured":"Salas, Y., M\u00e1rquez, A., Diaz, D. & Romero, L. Epidemiological study of mammary tumors in female dogs diagnosed during the period 2002\u20132012: a growing animal health problem. PLoS ONE 10, e0127381 (2015).","journal-title":"PLoS ONE"},{"key":"9587_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56194-z","volume":"14","author":"I Dolka","year":"2024","unstructured":"Dolka, I. et al. Risk factor analysis and clinicopathological characteristics of female dogs with mammary tumours from a single-center retrospective study in Poland. Sci. Rep. 14, 5569 (2024).","journal-title":"Sci. Rep."},{"key":"9587_CR44","first-page":"8195","volume":"15","author":"SM Abdelmegeed","year":"2018","unstructured":"Abdelmegeed, S. M. & Mohammed, S. Canine mammary tumors as a model for human disease. Oncol. Lett. 15, 8195\u20138205 (2018).","journal-title":"Oncol. Lett."},{"key":"9587_CR45","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s12276-023-00977-3","volume":"55","author":"JH Oh","year":"2023","unstructured":"Oh, J. H. & Cho, J.-Y. Comparative oncology: overcoming human cancer through companion animal studies. Exp. Mol. Med. 55, 725\u2013734 (2023).","journal-title":"Exp. Mol. Med."},{"key":"9587_CR46","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/cancers10090317","volume":"10","author":"K-H Lee","year":"2018","unstructured":"Lee, K.-H., Park, H.-M., Son, K.-H., Shin, T.-J. & Cho, J.-Y. Transcriptome signatures of canine mammary gland tumors and its comparison to human breast cancers. Cancers 10, 317 (2018).","journal-title":"Cancers"},{"key":"9587_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2023.1271097","volume":"10","author":"PT Carvalho","year":"2023","unstructured":"Carvalho, P. T. et al. Comparative epidemiological study of breast cancer in humans and canine mammary tumors: insights from Portugal. Front. Vet. Sci. 10, 1271097 (2023).","journal-title":"Front. Vet. Sci."},{"key":"9587_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/0300985810393258","volume":"48","author":"M Goldschmidt","year":"2011","unstructured":"Goldschmidt, M., Pe\u00f1a, L., Rasotto, R. & Zappulli, V. Classification and grading of canine mammary tumors. Vet. Pathol. 48, 117\u2013131 (2011).","journal-title":"Vet. Pathol."},{"key":"9587_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01705-5","volume":"25","author":"J Watson","year":"2023","unstructured":"Watson, J. et al. Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs. Breast Cancer Res. 25, 114 (2023).","journal-title":"Breast Cancer Res."},{"key":"9587_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-021-00273-1","volume":"7","author":"MM Williams","year":"2021","unstructured":"Williams, M. M. et al. MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer. npj Breast Cancer 7, 1\u201313 (2021).","journal-title":"npj Breast Cancer"},{"key":"9587_CR51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei, X. et al. Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. Cancer Lett. 470, 126\u2013133 (2020).","journal-title":"Cancer Lett."},{"key":"9587_CR52","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00018-017-2686-7","volume":"75","author":"D Ostroumov","year":"2017","unstructured":"Ostroumov, D., Fekete-Drimusz, N., Saborowski, M., K\u00fchnel, F. & Woller, N. CD4 and CD8 T lymphocyte interplay in controlling tumor growth. Cell. Mol. Life Sci. 75, 689\u2013713 (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"9587_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41389-018-0042-x","volume":"7","author":"A Brenot","year":"2018","unstructured":"Brenot, A., Knolhoff, B. L., DeNardo, D. G. & Longmore, G. D. SNAIL1 action in tumor cells influences macrophage polarization and metastasis in breast cancer through altered GM-CSF secretion. Oncogenesis 7, 1\u201313 (2018).","journal-title":"Oncogenesis"},{"key":"9587_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn7571","volume":"14","author":"EM Grasset","year":"2022","unstructured":"Grasset, E. M. et al. Triple-negative breast cancer metastasis involves complex epithelial\u2013mesenchymal transition dynamics and requires vimentin. Sci. Transl. Med 14, eabn7571 (2022).","journal-title":"Sci. Transl. Med"},{"key":"9587_CR55","doi-asserted-by":"publisher","unstructured":"Chandraganti, S. et al. CD4+ T-cells sensitize quasi-mesenchymal breast tumors lacking CD73 to anti-CTLA4 immune checkpoint blockade therapy. Preprint at https:\/\/doi.org\/10.1101\/2025.05.12.653467 (2025).","DOI":"10.1101\/2025.05.12.653467"},{"key":"9587_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-019-0149-8","volume":"6","author":"K-K Kim","year":"2019","unstructured":"Kim, K.-K. et al. Whole-exome and whole-transcriptome sequencing of canine mammary gland tumors. Sci. Data 6, 147 (2019).","journal-title":"Sci. Data"},{"key":"9587_CR57","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334\u20131347 (2021).","journal-title":"Nat. Genet."},{"key":"9587_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97430-0","volume":"11","author":"S Peralta","year":"2021","unstructured":"Peralta, S. et al. Comparative transcriptional profiling of canine acanthomatous ameloblastoma and homology with human ameloblastoma. Sci. Rep. 11, 17792 (2021).","journal-title":"Sci. Rep."},{"key":"9587_CR59","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3233\/BLC-201523","volume":"7","author":"BC Sommer","year":"2021","unstructured":"Sommer, B. C. et al. Basal and luminal molecular subtypes in naturally-occurring canine urothelial carcinoma are associated with tumor immune signatures and dog breed. Bladder Cancer 7, 317\u2013333 (2021).","journal-title":"Bladder Cancer"},{"key":"9587_CR60","doi-asserted-by":"publisher","first-page":"e1009450","DOI":"10.1371\/journal.pcbi.1009450","volume":"17","author":"GJ Tawa","year":"2021","unstructured":"Tawa, G. J. et al. Transcriptomic profiling in canines and humans reveals cancer specific gene modules and biological mechanisms common to both species. PLoS Comput. Biol. 17, e1009450 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"9587_CR61","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1158\/1078-0432.CCR-13-0545","volume":"19","author":"B Allard","year":"2013","unstructured":"Allard, B., Pommey, S., Smyth, M. J. & Stagg, J. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs. Clin. Cancer Res. 19, 5626\u20135635 (2013).","journal-title":"Clin. Cancer Res."},{"key":"9587_CR62","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/annonc\/mdx730","volume":"29","author":"L Buisseret","year":"2018","unstructured":"Buisseret, L. et al. Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial. Ann. Oncol. 29, 1056\u20131062 (2018).","journal-title":"Ann. Oncol."},{"key":"9587_CR63","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","volume":"74","author":"Y Zhu","year":"2014","unstructured":"Zhu, Y. et al. CSF1\/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 74, 5057\u20135069 (2014).","journal-title":"Cancer Res."},{"key":"9587_CR64","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.biopha.2017.05.056","volume":"91","author":"C Xu","year":"2017","unstructured":"Xu, C. et al. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway. Biomed. Pharmacother. 91, 1167\u20131177 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"9587_CR65","doi-asserted-by":"crossref","unstructured":"Finnson, K. W. et al. Identification of CD109 as part of the TGF-\u03b2 receptor system in human keratinocytes. FASEB J. 20, 1525\u20131527 (2006).","DOI":"10.1096\/fj.05-5229fje"},{"key":"9587_CR66","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s41416-020-0922-7","volume":"123","author":"X-T Mo","year":"2020","unstructured":"Mo, X.-T. et al. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma. Br. J. Cancer 123, 833\u2013843 (2020).","journal-title":"Br. J. Cancer"},{"key":"9587_CR67","doi-asserted-by":"publisher","first-page":"12083","DOI":"10.1007\/s13277-014-2509-5","volume":"35","author":"J Tao","year":"2014","unstructured":"Tao, J., Li, H., Li, Q. & Yang, Y. CD109 is a potential target for triple-negative breast cancer. Tumor Biol. 35, 12083\u201312090 (2014).","journal-title":"Tumor Biol."},{"key":"9587_CR68","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.3390\/cancers14153672","volume":"14","author":"S Zhou","year":"2022","unstructured":"Zhou, S. et al. CD109 is a critical determinant of EGFR expression and signaling, and tumorigenicity in squamous cell carcinoma cells. Cancers 14, 3672 (2022).","journal-title":"Cancers"},{"key":"9587_CR69","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/wrr.12023","volume":"21","author":"J Vorstenbosch","year":"2013","unstructured":"Vorstenbosch, J. et al. Transgenic mice overexpressing CD109 in the epidermis display decreased inflammation and granulation tissue and improved collagen architecture during wound healing. Wound Repair Regener. 21, 235\u2013246 (2013).","journal-title":"Wound Repair Regener."},{"key":"9587_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50694-z","volume":"9","author":"S Zhou","year":"2019","unstructured":"Zhou, S., da Silva, S. D., Siegel, P. M. & Philip, A. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro. Sci. Rep. 9, 16317 (2019).","journal-title":"Sci. Rep."},{"key":"9587_CR71","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3390\/cancers3021744","volume":"3","author":"LY Pang","year":"2011","unstructured":"Pang, L. Y., Cervantes-Arias, A., Else, R. W. & Argyle, D. J. Canine mammary cancer stem cells are radio- and chemo-resistant and exhibit an epithelial\u2013mesenchymal transition phenotype. Cancers 3, 1744\u20131762 (2011).","journal-title":"Cancers"},{"key":"9587_CR72","doi-asserted-by":"crossref","unstructured":"Filppu, P. et al. CD109\u2013GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity. JCI Insight 6, (2021).","DOI":"10.1172\/jci.insight.141486"},{"key":"9587_CR73","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/0300985812447830","volume":"50","author":"L Pe\u00f1a","year":"2013","unstructured":"Pe\u00f1a, L., De Andr\u00e9s, P. J., Clemente, M., Cuesta, P. & P\u00e9rez-Alenza, M. D. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics. Vet. Pathol. 50, 94\u2013105 (2013).","journal-title":"Vet. Pathol."},{"key":"9587_CR74","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1177\/10406387221090281","volume":"34","author":"DR Rissi","year":"2022","unstructured":"Rissi, D. R., McHale, B. J. & Miller, A. D. Primary nervous system lymphoma in cats. J. Vet. Diagn. Investig. 34, 712\u2013717 (2022).","journal-title":"J. Vet. Diagn. Investig."},{"key":"9587_CR75","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/10406387231220649","volume":"36","author":"JW Koehler","year":"2024","unstructured":"Koehler, J. W., Miller, A. D. & Rissi, D. R. Effects of autolysis and prolonged formalin fixation on histomorphology and immunohistochemistry of normal canine brain tissue: an experimental study. J. Vet. Diagn. Investig. 36, 169\u2013176 (2024).","journal-title":"J. Vet. Diagn. Investig."},{"key":"9587_CR76","doi-asserted-by":"publisher","unstructured":"Nelissen, S., Lavin, E. S., Armi\u00e9n, A. G. & Demeter, E. A. Histomorphological and ultrastructural characterization of pancreatic islet intranuclear and intracytoplasmic inclusions in giant southern pouched rats (Cricetomys ansorgei). Vet. Pathol. https:\/\/doi.org\/10.1177\/03009858251361140 (2025).","DOI":"10.1177\/03009858251361140"},{"key":"9587_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"9587_CR78","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"9587_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"9587_CR80","doi-asserted-by":"publisher","first-page":"e0157022","DOI":"10.1371\/journal.pone.0157022","volume":"11","author":"H Varet","year":"2016","unstructured":"Varet, H., Brillet-Gu\u00e9guen, L., Copp\u00e9e, J.-Y. & Dillies, M.-A. SARTools: a DESeq2- and EdgeR-based R pipeline for comprehensive differential analysis of RNA-Seq data. PLoS ONE 11, e0157022 (2016).","journal-title":"PLoS ONE"},{"key":"9587_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"9587_CR82","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. https:\/\/www.nature.com\/articles\/nbt.1754 (2011)."},{"key":"9587_CR83","doi-asserted-by":"publisher","unstructured":"Tarhan, L. et al. Single Cell Portal: an interactive home for single-cell genomics data. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.07.13.548886 (2023).","DOI":"10.1101\/2023.07.13.548886"},{"key":"9587_CR84","doi-asserted-by":"publisher","unstructured":"Bakhle, K. et al. CMC RNA-seq Data Analysis https:\/\/doi.org\/10.5281\/zenodo.17886650 (2025).","DOI":"10.5281\/zenodo.17886650"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09587-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09587-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09587-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:02:48Z","timestamp":1771855368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09587-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9587"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09587-x","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"303"}}